Healthcare & Life Sciences
Genomill Health
aliveseed
seed
Stage
1
Investors
About
Genomill Health develops molecular diagnostic tests that use patented Geno1® sample preparation technology, combining molecular biology, robotics, next-generation DNA sequencing, and artificial intelligence to improve scalability, cost, accuracy, and turnaround time of liquid biopsies and other diagnostics.
Explore Genomill Health's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.